Paul A. Offit

13.0k total citations · 1 hit paper
136 papers, 6.0k citations indexed

About

Paul A. Offit is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Paul A. Offit has authored 136 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Infectious Diseases, 46 papers in Animal Science and Zoology and 33 papers in Epidemiology. Recurrent topics in Paul A. Offit's work include Viral gastroenteritis research and epidemiology (81 papers), Animal Virus Infections Studies (46 papers) and Viral Infections and Immunology Research (32 papers). Paul A. Offit is often cited by papers focused on Viral gastroenteritis research and epidemiology (81 papers), Animal Virus Infections Studies (46 papers) and Viral Infections and Immunology Research (32 papers). Paul A. Offit collaborates with scholars based in United States, Japan and Australia. Paul A. Offit's co-authors include H. F. Clark, Harry B. Greenberg, K I Dudzik, Robert D. Shaw, Charlotte A. Moser, Jeffrey S. Gerber, Susan Coffin, Kevin O’Callaghan, John P. Moore and Stanley A. Plotkin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Paul A. Offit

130 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bivalent Covid-19 Vaccines — A Cautionary Tale

2023 65 citations Paul A. Offit New England Journal of Medicine profile →

Peers

Countries citing papers authored by Paul A. Offit

Since Specialization

Citations

This map shows the geographic impact of Paul A. Offit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Offit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Offit more than expected).

Fields of papers citing papers by Paul A. Offit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Offit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Offit. The network helps show where Paul A. Offit may publish in the future.

Co-authorship network of co-authors of Paul A. Offit

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Offit. A scholar is included among the top collaborators of Paul A. Offit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Offit. Paul A. Offit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia 2021 ·Vaccine ·Barbara J. Kuter, Safa Browne, Florence Momplaisir, Kristen A. Feemster, Angela K. Shen, Judith Green-McKenzie, Walter Faig, Paul A. Offit	100
2	The antivax movement and what allergists can do 2020 ·Annals of Allergy Asthma & Immunology ·(unknown), Paul A. Offit	3
3	Vaccine Safety: Myths and Misinformation 2020 ·Frontiers in Microbiology ·Sarah Geoghegan, Kevin O’Callaghan, Paul A. Offit	169
4	Challenges to Developing a Rotavirus Vaccine 2017 ·Viral Immunology ·Paul A. Offit	10
5	Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature 2017 ·Journal of the Pediatric Infectious Diseases Society ·Tomohiro Katsuta, (unknown), Paul A. Offit, Kristen A. Feemster	9
6	A Randomized Trial to Increase Acceptance of Childhood Vaccines by Vaccine-Hesitant Parents: A Pilot Study 2013 ·Academic Pediatrics ·Sarah E. Williams, Russell L. Rothman, Paul A. Offit, William Schaffner, (unknown), Kathryn M. Edwards	75
7	Should childhood vaccination be mandatory? Yes 2012 ·BMJ ·Paul A. Offit	10
8	Employee designation and health care worker support of an influenza vaccine mandate at a large pediatric tertiary care hospital 2011 ·Vaccine ·Kristen A. Feemster, (unknown), Michael J. Smith, Chris Feudtner, Arthur L. Caplan, Paul A. Offit, Susan Coffin	48
9	RotaTeq: A Pentavalent Bovine-Human Reassortant Rotavirus Vaccine 2006 ·Pediatric Annals ·Paul A. Offit, H. F. Clark	15
10	Rotavirus Vaccines: Round Two 2006 ·Human Vaccines ·Paul A. Offit	1
11	The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants 2006 ·The Pediatric Infectious Disease Journal ·H. F. Clark, Paul A. Offit, Stanley A. Plotkin, Penny M. Heaton	50
12	Development of a Pentavalent Rotavirus Vaccine against Prevalent Serotypes of Rotavirus Gastroenteritis 2005 ·The Journal of Infectious Diseases ·Penny M. Heaton, Michelle G. Goveia, Jacqueline M. Miller, Paul A. Offit, H. F. Clark	66
13	The Cutter Incident, 50 Years Later 2005 ·New England Journal of Medicine ·Paul A. Offit	81
14	Rotavirus Immunoglobulin A Responses Stimulated by Each of 3 Doses of a Quadrivalent Human/Bovine Reassortant Rotavirus Vaccine 2004 ·The Journal of Infectious Diseases ·Richard L. Ward, David I. Bernstein, Vicki E. Smith, D. S. Sander, Alan Shaw, Joseph Eiden, Penny M. Heaton, Paul A. Offit, H. F. Clark	39
15	Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants 2004 ·The Journal of Pediatrics ·H. F. Clark, David I. Bernstein, Penelope H. Dennehy, Paul A. Offit, Michael E. Pichichero, John J. Treanor, Richard L. Ward, David L. Krah, Alan Shaw, Michael J. Dallas, (unknown), Joseph Eiden, Nathalie Ivanoff, Karen M. Kaplan, Penny M. Heaton	116
16	Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation 2003 ·The Pediatric Infectious Disease Journal ·H. F. Clark, Carl J. Burke, David B. Volkin, Paul A. Offit, Richard L. Ward, Joseph Bresee, Penelope H. Dennehy, Willis M. Gooch, (unknown), (unknown), Emmanuel B. Walter, Barbara Watson, David L. Krah, Michael J. Dallas, (unknown), Karen M. Kaplan, Penny M. Heaton	51
17	Hypertrophy, Hyperplasia, and Infectious Virus in Gut‐Associated Lymphoid Tissue of Mice after Oral Inoculation with Simian‐Human or Bovine‐Human Reassortant Rotaviruses 2001 ·The Journal of Infectious Diseases ·Charlotte A. Moser, Douglas V. Dolfi, (unknown), (unknown), Paul A. Offit, H. F. Clark	27
18	A quantitative luminescence assay for measuring cell uptake of aqueous-based microcapsules in vitro 2000 ·Journal of Immunological Methods ·J O Brubaker, (unknown), Tully J. Speaker, Paul A. Offit	6
19	Rotavirus-specific proteins are detected in murine macrophages in both intestinal and extraintestinal lymphoid tissues 1998 ·Microbial Pathogenesis ·Kurt Brown, Paul A. Offit	47
20	Rotavirus Pathology and Pathophysiology 1994 ·Current topics in microbiology and immunology ·Harry B. Greenberg, H. F. Clark, Paul A. Offit	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact